{"title":"Research progress in hematopoietic stem cell transplantation for bone marrow acute radiation syndrome","authors":"Wang Jing, Zhou Fang","doi":"10.13491/J.ISSN.1004-714X.2021.03.024","DOIUrl":null,"url":null,"abstract":"As is known, the nuclear accident resulting from the explosion of a nuclear weapon\n or the release of nuclear material could cause acute radiation syndrome within a short\n time. The study had found that the dose of > 0.7 Gy radiation on human body can result\n in persistent myelosuppression, a kind of acute radiation syndrome, leading to pancytopenia,\n bleeding, infection and other injuries. Several evidences also have shown that hematopoietic\n stem cell is conducive to repair hematopoietic injury in bone marrow, improve hematopoietic\n microenvironment and promote hematopoietic reconstruction. Therefore, hematopoietic\n stem cell transplantation is widely considered as the main treatment of the bone marrow\n acute radiation syndrome. However, before a surgery of hematopoietic stem cell transplantation,\n it still needs more research on donor selection, formulation of preconditioning and\n prevention of complications such as grafl-versus-host disease. This paper mainly summarizes\n the application and research progress of hematopoietic stem cell transplantation in\n treating radiation injury.\n 摘要: 核武器爆炸或核物质泄漏导致的核事故, 短时间内会造成急性放射病。人体接受剂量 >0.7 Gy 辐射可导致骨 髓持久抑制即急性放射病, 引起全血细胞减少、出血、感染等损伤。大量研宄显示,\n 造血干细胞移植是治疗骨髓型急性 放射性疾病的主要手段。造血干细胞可以修复骨髓造血损伤, 改善造血微环境, 促进造血重建。在使用造血干细胞移 植术前选择供者、制定预处理方案及预防移植物抗宿主病等并发症的方案仍需要研宄,\n 本文主要概述了造血干细胞移 植在辐射损伤中的应用及研宄进展。","PeriodicalId":58844,"journal":{"name":"中国辐射卫生","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国辐射卫生","FirstCategoryId":"1087","ListUrlMain":"https://doi.org/10.13491/J.ISSN.1004-714X.2021.03.024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
As is known, the nuclear accident resulting from the explosion of a nuclear weapon
or the release of nuclear material could cause acute radiation syndrome within a short
time. The study had found that the dose of > 0.7 Gy radiation on human body can result
in persistent myelosuppression, a kind of acute radiation syndrome, leading to pancytopenia,
bleeding, infection and other injuries. Several evidences also have shown that hematopoietic
stem cell is conducive to repair hematopoietic injury in bone marrow, improve hematopoietic
microenvironment and promote hematopoietic reconstruction. Therefore, hematopoietic
stem cell transplantation is widely considered as the main treatment of the bone marrow
acute radiation syndrome. However, before a surgery of hematopoietic stem cell transplantation,
it still needs more research on donor selection, formulation of preconditioning and
prevention of complications such as grafl-versus-host disease. This paper mainly summarizes
the application and research progress of hematopoietic stem cell transplantation in
treating radiation injury.
摘要: 核武器爆炸或核物质泄漏导致的核事故, 短时间内会造成急性放射病。人体接受剂量 >0.7 Gy 辐射可导致骨 髓持久抑制即急性放射病, 引起全血细胞减少、出血、感染等损伤。大量研宄显示,
造血干细胞移植是治疗骨髓型急性 放射性疾病的主要手段。造血干细胞可以修复骨髓造血损伤, 改善造血微环境, 促进造血重建。在使用造血干细胞移 植术前选择供者、制定预处理方案及预防移植物抗宿主病等并发症的方案仍需要研宄,
本文主要概述了造血干细胞移 植在辐射损伤中的应用及研宄进展。
As is known, the nuclear accident resulting from the exploration of a nuclear weapon or the release of nuclear material could cause acute radiation syndrome within a short time The study had found that the dose of>0.7 Gy radiation on human body can result in persistent myelosupression, a kind of acute radiation syndrome, leading to pancytopia, bleeding, infection and other injuries Several opinions also have shown that homeopathic stem cells are conductive to repair homeopathic injury in bone row, improve homeopathic microenvironment and promote homeopathic reconstruction Theoretical, hematological stem cell transplantation is widely considered as the main treatment of the bone marrow acute radiation syndrome How, before a large sum of hematological stem cell transmission, it still needs more research on donor selection, formulation of preconditioning and prevention of complications such as grafl Versus host disease This paper mainly summarizes the application and research progress of hematological stem cell transplantation in treating radiation injury Abstract: Nuclear accidents caused by nuclear weapon explosions or nuclear material leaks can cause acute radiation sickness in a short period of time. The human body can receive radiation with a dose greater than 0.7 Gy, which can lead to persistent bone marrow suppression, namely acute radiation sickness, causing damage such as whole blood cell reduction, bleeding, and infection. Numerous studies have shown that hematopoietic stem cell transplantation is the main method for treating acute radiation sickness of bone marrow type. Hematopoietic stem cells can repair bone marrow hematopoietic damage, improve the hematopoietic microenvironment, and promote hematopoietic reconstruction. There is still a need to study the selection of donors, formulation of pre-treatment plans, and prevention of complications such as graft versus host disease before using hematopoietic stem cell transplantation. This article mainly outlines the application and research progress of hematopoietic stem cell transplantation in radiation damage.
期刊介绍:
Chinese Journal of Radiological Health is one of the Source Journals for Chinese Scientific and Technical Papers and Citations and belongs to the series published by Chinese Preventive Medicine Association (CPMA). It is a national academic journal supervised by National Health Commission of the People’s Republic of China and co-sponsored by Institute of Radiation Medicine, Shandong Academy of Medical Sciences and CPMA, and is a professional academic journal publishing research findings and management experience in the field of radiological health, issued to the public in China and abroad. Under the guidance of the Communist Party of China and the national press and publication policies, the Journal actively publicizes the guidelines and policies of the Party and the state on health work, promotes the implementation of relevant laws, regulations and standards, and timely reports new achievements, new information, new methods and new products in the specialty, with the aim of organizing and promoting the academic communication of radiological health in China and improving the academic level of the specialty, and for the purpose of protecting the health of radiation workers and the public while promoting the extensive use of radioisotopes and radiation devices in the national economy. The main columns include Original Articles, Expert Comments, Experience Exchange, Standards and Guidelines, and Review Articles.